日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multicentre, randomized, double-blind, prospective study on the effects of ImmunoAdSorptiOn on cardiac function in patients with Dilated CardioMyopathy (IASO-DCM): Rationale and design

一项关于免疫吸附对扩张型心肌病患者心脏功能影响的多中心、随机、双盲、前瞻性研究(IASO-DCM):研究原理和设计

Dörr, Marcus; Böhm, Michael; Erdmann, Erland; Groß, Stefan; Mahabadi, Amir-Abbas; Nauck, Matthias; Nickening, Georg; Schultheiss, Heinz-Peter; Staudt, Alexander; Werdan, Karl; Waagstein, Finn; Hjalmarson, Åke; Felix, Stephan B

Reduced right ventricular ejection fraction and increased mortality in chronic systolic heart failure patients receiving β-blockers: insights from the BEST trial

接受β受体阻滞剂治疗的慢性收缩性心力衰竭患者右心室射血分数降低和死亡率增加:来自BEST试验的启示

Desai, Ravi V; Guichard, Jason L; Mujib, Marjan; Ahmed, Mustafa I; Feller, Margaret A; Fonarow, Gregg C; Meyer, Philippe; Iskandrian, Ami E; Bogaard, Herman J; White, Michel; Aban, Inmaculada B; Aronow, Wilbert S; Deedwania, Prakash; Waagstein, Finn; Ahmed, Ali

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial

老年心力衰竭患者比索洛尔与卡维地洛滴定至目标剂量:CIBIS-ELD试验

Düngen, Hans-Dirk; Apostolovic, Svetlana; Inkrot, Simone; Tahirovic, Elvis; Töpper, Agnieszka; Mehrhof, Felix; Prettin, Christiane; Putnikovic, Biljana; Neskovic, Aleksandar N; Krotin, Mirjana; Sakac, Dejan; Lainscak, Mitja; Edelmann, Frank; Wachter, Rolf; Rau, Thomas; Eschenhagen, Thomas; Doehner, Wolfram; Anker, Stefan D; Waagstein, Finn; Herrmann-Lingen, Christoph; Gelbrich, Goetz; Dietz, Rainer

An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial

对瑞舒伐他汀治疗收缩性心力衰竭的经济学评价:来自 CORONA 试验的证据

Lorgelly, Paula K; Briggs, Andrew H; Wedel, Hans; Dunselman, Peter; Hjalmarson, Ake; Kjekshus, John; Waagstein, Finn; Wikstrand, John; Jánosi, András; van Veldhuisen, Dirk J; Barrios, Vivencio; Fonseca, Cândida; McMurray, John J V

Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide

在心力衰竭患者接受瑞舒伐他汀治疗的多国对照试验(CORONA)中,预测致命和非致命结局的因素:载脂蛋白A-1、高敏C反应蛋白和N末端B型利钠肽前体(NT-proBNP)的增量价值

Wedel, Hans; McMurray, John J V; Lindberg, Magnus; Wikstrand, John; Cleland, John G F; Cornel, Jan H; Dunselman, Peter; Hjalmarson, Ake; Kjekshus, John; Komajda, Michel; Kuusi, Timo; Vanhaecke, Johan; Waagstein, Finn

Low-Dose Digoxin and Reduction in Mortality and Morbidity in Heart Failure

低剂量地高辛可降低心力衰竭患者的死亡率和发病率

Ahmed, Ali; Waagstein, Finn

Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial

地高辛在降低慢性心力衰竭患者一年死亡率方面的有效性:洋地黄研究组试验

Ahmed, Ali; Waagstein, Finn; Pitt, Bertram; White, Michel; Zannad, Faiez; Young, James B; Rahimtoola, Shahbudin H

Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial

低血清浓度地高辛对心力衰竭患者死亡率和住院率的影响:DIG试验的倾向性匹配研究

Ahmed, Ali; Pitt, Bertram; Rahimtoola, Shahbudin H; Waagstein, Finn; White, Michel; Love, Thomas E; Braunwald, Eugene

Silent myocardial infarction in women with type II diabetes mellitus and microalbuminuria

患有 II 型糖尿病和微量白蛋白尿的女性发生无症状性心肌梗死

Omerovic, Elmir; Brohall, Gerhard; Müller, Markus; Råmunddal, Truls; Matejka, Göran; Waagstein, Finn; Fagerberg, Björn

Factors associated with survival to hospital discharge among patients hospitalised alive after out of hospital cardiac arrest: change in outcome over 20 years in the community of Göteborg, Sweden

院外心脏骤停后存活住院患者出院生存相关因素:瑞典哥德堡社区20年来的预后变化

Herlitz, J; Bång, A; Gunnarsson, J; Engdahl, J; Karlson, B W; Lindqvist, J; Waagstein, L